Videos SEASON 3

The role of Vydura▼ (rimegepant) in primary and secondary care: Identifying suitable patients and the value of return to normal function

Join us for series 3 of MDTV as Dr Gina Kennedy, Consultant Neurologist and Dr David Watson, GPwER in Headache review and discuss the role of Vydura in both primary and secondary care and hear them present real-world case studies on patient suitability and return to normal function.

Continue watching
Knowledge Check & CDP Certificate

View all episodes within this season, then complete the knowledge check and earn your CPD certificate

Card image cap
EPISODE 1

Dr Gina Kennedy, Consultant Neurologist and Dr David Watson, GPwER in Headache

The role of Vydura in primary care: What makes a patient suitable for Vydura?

10m

START NOW
Card image cap
EPISODE 2

Dr Gina Kennedy, Consultant Neurologist and Dr David Watson, GPwER in Headache

The role of Vydura in primary care: Return to normal function is a key benefit

7m

START NOW
Card image cap
EPISODE 3

Dr Gina Kennedy, Consultant Neurologist and Dr David Watson, GPwER in Headache

The role of Vydura in the preventive treatment landscape

15m

START NOW
Card image cap
EPISODE 4

Dr David Watson, GPwER in Headache

The role of Vydura in primary care: Patient suitability and returning to normal function (case study)

5m

START NOW
Card image cap
EPISODE 5

Dr Gina Kennedy, Consultant Neurologist

The role of Vydura in primary care: Patient suitability and returning to normal function (case study)

3m

START NOW